E-LIB Suche - Ergebnisse für: Oriol, A. (Albert)

1

Nivolumab, Pomalidomide, and Elotuzumab Combination Regimen..:

Oriol, Albert ; Hájek, Roman ; Spicka, Ivan...
Clinical Lymphoma Myeloma and Leukemia. , 2024

2

Pomalidomide, Bortezomib, and Dexamethasone in Lenalidomide..:

Oriol, Albert ; Dimopoulos, Meletios ; Schjesvold, Fredrik...
Clinical Lymphoma Myeloma and Leukemia. 24 (2024) 3 - p. 165-176.e4 , 2024

Link: https://doi.org/10.1016/..

3

An open-label phase 2 study treating patients with first or..:

Perrot, Aurore ; Delimpasi, Sosana ; Spanoudakis, Emmanouil...
Leukemia & Lymphoma. 65 (2024) 6 - p. 833-842 , 2024

Link: https://doi.org/10.1080/..

4

Digitale Gesundheitsplattformen – Beispiele für Datenmanage..:

, In: Health Data Management,

Oriol, Albert ; Meier, Pierre-Michael ; Ebling, Frank... - p. 441-454 , 2024

Link: https://doi.org/10.1007/..

5

Single-point and kinetics of peripheral residual disease by..:

Puig, Noemí ; Agulló, Cristina ; Contreras, Teresa...
Haematologica. , 2024

Link: https://doi.org/10.3324/..

6

Safety and efficacy of belantamab mafodotin with pembrolizu..:

Suvannasankha, Attaya ; Bahlis, Nizar ; Trudel, Suzanne...
Cancer. , 2024

Link: https://doi.org/10.1002/..

7

Teclistamab Improves Patient-Reported Symptoms and Health-R..:

Martin, Thomas G. ; Moreau, Philippe ; Usmani, Saad Z....
Clinical Lymphoma Myeloma and Leukemia. 24 (2024) 3 - p. 194-202 , 2024

Link: https://doi.org/10.1016/..

8

Selinexor, daratumumab, bortezomib and dexamethasone for th..:

González-Calle, Verónica ; Rodríguez-Otero, Paula ; Sureda, Anna...
Haematologica. , 2024

Link: https://doi.org/10.3324/..

9

CD200 genotype is associated with clinical outcome of patie..:

Gonzalez-Montes, Yolanda ; Osca-Gelis, Gemma ; Rodriguez-Romanos, Rocío...
Frontiers in Immunology. 15 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

10

Automated prioritization of sick newborns for whole genome ..:

Peterson, Bennet ; Hernandez, Edgar Javier ; Hobbs, Charlotte...
Genome Medicine. 15 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

11

OA-12 Predictors of unsustained measurable residual disease..:

Guerrero, Camila ; Puig, Noemi ; Cedena, Teresa...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S7-S8 , 2023

Link: https://doi.org/10.1016/..

12

Daratumumab, carfilzomib, and dexamethasone in relapsed or ..:

Moreau, Philippe ; Chari, Ajai ; Oriol, Albert...
Blood Cancer Journal. 13 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

13

OA-45 Pharmacokinetic and correlative analysis of ciltacabt..:

de Larrea, Carlos Fernández ; Harrison, Simon ; Martinez-Lopez, Joaquín...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S28 , 2023

Link: https://doi.org/10.1016/..

14

P883: ALNUCTAMAB (ALNUC; BMS-986349; CC-93269), A BCMA × CD..:

Wong, Sandy W. ; Bar, Noffar ; Victoria Mateos, María...
HemaSphere. 7 (2023) S3 - p. e1220745 , 2023

Link: https://doi.org/10.1097/..

15

P-265 Mezigdomide (MEZI) monotherapy in relapsed/ refractor..:

Goldsmith, Scott ; Oriol, Albert ; Anttila, Pekka...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S181-S182 , 2023

Link: https://doi.org/10.1016/..